PE20091038A1 - Bisfosfonatos de alquilo de 2 a 5 atomos de carbono-imidazol - Google Patents

Bisfosfonatos de alquilo de 2 a 5 atomos de carbono-imidazol

Info

Publication number
PE20091038A1
PE20091038A1 PE2008001990A PE2008001990A PE20091038A1 PE 20091038 A1 PE20091038 A1 PE 20091038A1 PE 2008001990 A PE2008001990 A PE 2008001990A PE 2008001990 A PE2008001990 A PE 2008001990A PE 20091038 A1 PE20091038 A1 PE 20091038A1
Authority
PE
Peru
Prior art keywords
phosphone
imidazol
hydroxy
ethyl
carbon atoms
Prior art date
Application number
PE2008001990A
Other languages
English (en)
Inventor
Sven Weiler
Leo Widler
Jean-Michel Rondeau
Simona Cotesta
Wolfgang Jahnke
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39154111&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20091038(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20091038A1 publication Critical patent/PE20091038A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE ACIDOS [(IMIDAZOL-1-IL)-1-HIDROXI-1-FOSFONO-ETIL]-FOSFONICOS SUSTITUIDOS POR ALQUILO(C2-C5) DE FORMULA (I) DONDE UNO DE R1 Y R2 ES H, Y EL OTRO ES ALQUILO(C2-C5). SON COMPUESTOS PREFERIDOS: ACIDO [2-(4-PROPIL-IMIDAZOL-1-IL)-1-HIDROXI-1-FOSFONO-ETIL]-FOSFONICO, ACIDO [2-(4-BUTIL-IMIDAZOL-1-IL)-1-HIDROXI-1-FOSFONO-ETIL]-FOSFONICO, ACIDO [1-HIDROXI-2-(4-ISOPROPIL-IMIDAZOL-1-IL)-1-FOSFONO-ETIL]-FOSFONICO, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS INHIBEN LA RESORCION OSEA EXCESIVA O INAPROPIADA SIENDO UTILES EN EL TRATAMIENTO DE OSTEOPOROSIS, OSTEOPENIA, OSTEOARTRITIS, ARTRITIS REUMATOIDE
PE2008001990A 2007-11-30 2008-11-27 Bisfosfonatos de alquilo de 2 a 5 atomos de carbono-imidazol PE20091038A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07122016 2007-11-30

Publications (1)

Publication Number Publication Date
PE20091038A1 true PE20091038A1 (es) 2009-08-19

Family

ID=39154111

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001990A PE20091038A1 (es) 2007-11-30 2008-11-27 Bisfosfonatos de alquilo de 2 a 5 atomos de carbono-imidazol

Country Status (24)

Country Link
US (2) US7977323B2 (es)
EP (1) EP2225252B1 (es)
JP (1) JP5244917B2 (es)
KR (1) KR20100092035A (es)
CN (1) CN101835787A (es)
AR (1) AR069437A1 (es)
AU (1) AU2008328797B2 (es)
BR (1) BRPI0819902A2 (es)
CA (1) CA2701516A1 (es)
CL (1) CL2008003545A1 (es)
CO (1) CO6280421A2 (es)
CR (1) CR11362A (es)
EA (1) EA201000860A1 (es)
EC (1) ECSP10010321A (es)
ES (1) ES2386851T3 (es)
IL (1) IL204657A0 (es)
MA (1) MA31895B1 (es)
MX (1) MX2010005786A (es)
NZ (1) NZ584219A (es)
PE (1) PE20091038A1 (es)
TN (1) TN2010000138A1 (es)
TW (1) TW200932248A (es)
WO (1) WO2009068567A1 (es)
ZA (1) ZA201001992B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110034418A1 (en) * 2008-04-04 2011-02-10 Karen Beltz Pharmaceutical composition with bisphosphonate
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
CA2769633C (en) 2009-07-31 2017-06-06 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US9290526B2 (en) 2010-05-28 2016-03-22 The Royal Institution For The Advancement Of Learning/Mcgill University Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
US8816082B2 (en) 2010-05-28 2014-08-26 The Royal Institution For The Advancement Of Learning/Mcgill University Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
CN102659840B (zh) * 2012-05-10 2013-08-14 苏州普瑞诺药物技术有限公司 咪唑双膦酸类化合物及其可药用盐及药物用途
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability
CN111225672B (zh) 2017-10-16 2023-09-29 清华大学 甲羟戊酸通路抑制剂及其药物组合物
CN112980809B (zh) * 2021-03-17 2023-04-11 云南中烟工业有限责任公司 一种烟草法尼基焦磷酸合酶基因及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84497A (en) 1986-11-21 1994-10-21 Ciba Geigy Ag History 2-) Imidazol-1-yl (ethane-1,1-diphosphonic acid, their preparation and pharmaceutical preparations containing them
DK0573604T3 (da) * 1991-02-26 1995-05-29 Procter & Gamble Pharma Fremgangsmåde til behandling af osteoporosis
GB9324143D0 (en) 1993-11-24 1994-01-12 Schering Agrochemicals Ltd Triazole phosphonate pesticides
GB0029018D0 (en) * 2000-11-28 2001-01-10 Strakan Group Plc Dermatological formulations
GB0029111D0 (en) 2000-11-29 2001-01-10 Novartis Ag Organic compounds
WO2008128056A1 (en) 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
US7358361B2 (en) 2004-10-08 2008-04-15 The Board Of Trustees Of The University Of Illinois Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
AR063121A1 (es) 2006-10-05 2008-12-30 Novartis Ag Composicion farmaceutica
CA2682231A1 (en) 2007-03-28 2008-10-09 Array Biopharma Inc. Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors

Also Published As

Publication number Publication date
ES2386851T3 (es) 2012-09-03
EP2225252A1 (en) 2010-09-08
WO2009068567A1 (en) 2009-06-04
MX2010005786A (es) 2010-06-09
US7977323B2 (en) 2011-07-12
AR069437A1 (es) 2010-01-20
CL2008003545A1 (es) 2009-06-05
MA31895B1 (fr) 2010-12-01
CO6280421A2 (es) 2011-05-20
JP5244917B2 (ja) 2013-07-24
CR11362A (es) 2010-06-14
EA201000860A1 (ru) 2010-12-30
US20090143337A1 (en) 2009-06-04
TN2010000138A1 (en) 2011-09-26
TW200932248A (en) 2009-08-01
CA2701516A1 (en) 2009-06-04
KR20100092035A (ko) 2010-08-19
IL204657A0 (en) 2010-11-30
JP2011504908A (ja) 2011-02-17
CN101835787A (zh) 2010-09-15
AU2008328797B2 (en) 2011-11-03
EP2225252B1 (en) 2012-06-27
ZA201001992B (en) 2010-12-29
BRPI0819902A2 (pt) 2015-05-19
US20110224173A1 (en) 2011-09-15
AU2008328797A1 (en) 2009-06-04
ECSP10010321A (es) 2010-08-31
NZ584219A (en) 2012-03-30

Similar Documents

Publication Publication Date Title
PE20091038A1 (es) Bisfosfonatos de alquilo de 2 a 5 atomos de carbono-imidazol
CY1121703T1 (el) Ιατρικη χρηση του πολυμορφου a toy ibanδρονικου
PE20080359A1 (es) Compuestos de benzoxazol y benzotiazol 6-0-sustituidos y metodos de inhibicion de la senalizacion de csf-1r
PE20120690A1 (es) Derivados de 5-fluoropirimidinona
EP2743268A3 (en) Fused cyclic compounds as GPR40 receptor modulators
UY30620A1 (es) Derivados de piridido[4,3-d]pirimidin-4(3h)-ona como antagonistas de los receptores de calcio
UA110924C2 (uk) Мезоіонні пестициди
PE20091222A1 (es) Bifenilo sustituidos como moduladores del receptor gpra40
PE20081545A1 (es) Derivados de sulfonamida como inhibidores de acido graso sintasas
AR080870A1 (es) Propanoato cristalino de (s)-isopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-4-fluoro-3-hidroxi-4-metiltetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino, composiciones farmaceuticas que los contienen y uso del mismo en el tratamiento de infecciones virales, en particul
MX2011011485A (es) Sulfonamidas nematocidas.
PE20120599A1 (es) Metodo para producir material de sabor
EA201270410A1 (ru) Производное инденона и содержащая его фармацевтическая композиция
MX2012001651A (es) Pesticidas mesoionicos.
AR047972A1 (es) Derivado de bencimidazol, proceso de obtencion y composiciones farmaceuticas.
MX2012001646A (es) Pesticidas mesoionicos.
BRPI0607093A2 (pt) polimorfo cristalino de monoidrato de sal monossódico de ácido 3-(n-metil-n-pentil)amino-1-hidroxipropano-1, 1-difosfÈnico, ibandronato, processo para a preparação de um polimorfo de ibandronato cristalino, e composição farmacêutica que o compreende
TW200833682A (en) Pharmaceutical compounds
EA200801261A1 (ru) Фармацевтические композиции на основе галлия и способы
MY147951A (en) Crystalline potassium salt of lipoxin a? analogs
IN2014CN03646A (es)
EA201490704A1 (ru) Композиции антиперспиранта и способ уменьшения потоотделения
WO2007074475A3 (en) Novel polymorphic forms of ibandronate
RU2017116178A (ru) Замещенные ароматические соединения и фармацевтические композиции для предотвращения и лечения остеопороза
PE20050293A1 (es) Derivados de aminoacidos sustituidos con cicloalquilo, procedimiento para su preparacion y su uso como medicamentos

Legal Events

Date Code Title Description
FC Refusal